- Home
- FA vs OCUL Comparison
FA vs OCUL Comparison
Compare FA & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FA
- OCUL
- Stock Information
- Founded
- FA 2003
- OCUL 2006
- Country
- FA United States
- OCUL United States
- Employees
- FA 10000
- OCUL N/A
- Industry
- FA Business Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- FA Consumer Discretionary
- OCUL Health Care
- Exchange
- FA Nasdaq
- OCUL Nasdaq
- Market Cap
- FA 2.2B
- OCUL 2.3B
- IPO Year
- FA 2021
- OCUL 2014
- Fundamental
- Price
- FA $14.14
- OCUL $10.74
- Analyst Decision
- FA Buy
- OCUL Strong Buy
- Analyst Count
- FA 4
- OCUL 10
- Target Price
- FA $20.67
- OCUL $22.33
- AVG Volume (30 Days)
- FA 784.0K
- OCUL 2.5M
- Earning Date
- FA 11-06-2025
- OCUL 11-04-2025
- Dividend Yield
- FA N/A
- OCUL N/A
- EPS Growth
- FA N/A
- OCUL N/A
- EPS
- FA N/A
- OCUL N/A
- Revenue
- FA $1,251,464,000.00
- OCUL $55,783,000.00
- Revenue This Year
- FA $84.14
- OCUL N/A
- Revenue Next Year
- FA $5.93
- OCUL $17.75
- P/E Ratio
- FA N/A
- OCUL N/A
- Revenue Growth
- FA 65.34
- OCUL N/A
- 52 Week Low
- FA $12.25
- OCUL $5.79
- 52 Week High
- FA $20.79
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- FA 49.60
- OCUL 37.44
- Support Level
- FA $12.25
- OCUL $10.40
- Resistance Level
- FA $14.75
- OCUL $12.10
- Average True Range (ATR)
- FA 0.55
- OCUL 0.44
- MACD
- FA -0.01
- OCUL -0.08
- Stochastic Oscillator
- FA 70.40
- OCUL 17.31
About FA First Advantage Corporation
First Advantage Corp is a provider of global software and data in the Human Resources technology industry. The company leverages proprietary technology and AI across its platforms, data, and APIs to deliver comprehensive background screening, digital identity, and verification solutions driven by innovation, automation, and customer success. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment. The group serves customers in over 200 countries and territories, modernising hiring and onboarding on a global scale.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.